Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OR › Corvallis › NPI 1740668649
Physician

Corvallis Medical Group LLC

Corvallis Medical Group LLC was paid $1.18M by Medicaid between Jan 2018 and Nov 2024, across 30 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.

33Billing provider infoCORVALLIS MEDICAL GROUP LLC
CORVALLIS, OR 97330
33aNPI1740668649assigned 05/11/2015
33bProvider typePain Medicine Physician
28Total paid$1.18M
24GClaims36,463
24DCodes billed30
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20186,467$404K
201912,041$259K
20209,135$226K
20214,137$160K
20221,843$42K
20231,327$32K
2024incomplete1,513$59K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 35% 9,607 7,606 $417K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 22% 8,968 7,014 $259K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 14% 1,786 1,656 $166K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 11% 2,320 2,163 $133K
99484 8.0% 3,893 2,784 $94K
80305 3.2% 1,565 1,388 $38K
20553 2.3% 1,002 679 $27K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1.7% 187 176 $20K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 77 65 $9K
96127 <1% 1,981 1,711 $8K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 527 464 $6K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 116 109 $4K
18 more codes
96160 <1% 100 $774.68
99215 Doctor's office visit, returning patient (complex) <1% 15 $696.15
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes <1% 17 $20.73
96130 <1% 17 $8.80
96138 <1% 17 $1.17
G9578 Documentation of signed opioid treatment agreement at least once during opioid therapy <1% 716 $0.06
G9903 Patient screened for tobacco use and identified as a tobacco non-user <1% 326 $0.01
1036F 0% 327 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 0% 54 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 0% 54 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 57 $0.00
96132 0% 17 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 791 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 0% 777 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 566 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 0% 511 $0.00
4004F 0% 55 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRASK, JULIA (CHIEF FINANCIAL OFFICER)